Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
168.33
Oct 22 • 3:59 PM ET Dollar change+7.49 Percentage change(4.66%)
Aftermarket Close
165.97
Aftermarket • 7:35 PM ET Dollar change-2.36 Percentage change(-1.40%)
Index
RUT
Market Cap
4.21B
Enterprise Value
5.20B
Income
30.09M
Sales
2.16B
Book/sh
86.05
Cash/sh
11.93
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
13000
IPO
Mar 31, 1992
P/E
142.19
Forward P/E
17.41
PEG
1.70
P/S
1.95
P/B
1.96
P/C
14.11
P/FCF
27.54
EV/EBITDA
14.89
EV/Sales
2.41
Quick Ratio
1.17
Current Ratio
2.39
Debt/Eq
0.60
LT Debt/Eq
0.58
Option/Short
Yes / Yes
EPS (ttm)
1.18
EPS next Y
9.67
EPS next Q
2.14
EPS this Y
12.63%
EPS next Y
10.61%
EPS next 5Y
10.24%
EPS past 3/5Y
- -62.61%
Sales past 3/5Y
-0.68% 11.90%
EPS Y/Y TTM
179.33%
Sales Y/Y TTM
-8.84%
EPS Q/Q
-46.71%
Sales Q/Q
0.64%
Insider Own
1.77%
Insider Trans
-9.14%
Inst Own
104.55%
Inst Trans
1.34%
ROA
0.74%
ROE
1.41%
ROIC
0.88%
Gross Margin
34.50%
Oper. Margin
6.68%
Profit Margin
1.39%
SMA20
4.05%
SMA50
1.18%
SMA200
13.63%
Trades
Shs Outstand
25.01M
Shs Float
24.56M
52W High
192.85 -12.71%
52W Low
113.37 48.48%
Volatility
2.96% 2.63%
ATR (14)
4.55
RSI (14)
58.94
Beta
0.89
Rel Volume
0.90
Avg Volume
268.84K
Volume
241,795
Perf Week
0.66%
Perf Month
3.07%
Perf Quarter
6.92%
Perf Half Y
35.15%
Perf YTD
17.99%
Perf Year
37.58%
Perf 3Y
55.75%
Perf 5Y
-25.50%
Perf 10Y
18.20%
Prev Close
160.84
Price
168.33
Change %
4.66%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanzone Virginia RuthVP, General CounselSep 03 '26Sale168.694,856819,15014,604Sep 03 06:29 PM
VIRGINIA SANZONEOfficerSep 03 '26Proposed Sale168.694,856819,150Sep 03 04:02 PM
Bonnell Brian MichaelChief Financial OfficerSep 01 '26Sale175.006,3811,116,67556,062Sep 01 05:21 PM
BRIAN BONNELLOfficerSep 01 '26Proposed Sale175.006,3811,116,675Sep 01 04:07 PM
Bonnell Brian MichaelChief Financial OfficerAug 31 '26Sale172.799,3071,608,14362,443Aug 31 04:43 PM
BRIAN BONNELLOfficerAug 31 '26Proposed Sale172.799,3071,608,143Aug 31 04:13 PM
Woolson DanielVP, GM-Infusion CapitalAug 13 '26Sale181.335,417982,26517,062Aug 13 06:56 PM
DANIEL WOOLSONOfficerAug 13 '26Proposed Sale181.335,417982,265Aug 13 04:17 PM
Sousa BenChief Information OfficerAug 12 '26Sale178.322,250401,2093,076Aug 12 04:33 PM
BENJAMIN SOUSAOfficerAug 12 '26Proposed Sale178.322,250401,209Aug 12 04:24 PM
Voigtlander Christian B.Chief Operating OfficerAug 11 '26Sale182.938,9291,633,40437,377Aug 11 06:18 PM
FINNEY ELISHA WDirectorAug 11 '26Sale182.4837868,9784,871Aug 11 05:59 PM
CHRISTIAN VOIGTLANDEROfficerAug 11 '26Proposed Sale182.938,9291,633,404Aug 11 04:32 PM
ELISHA W FINNEYDirectorAug 11 '26Proposed Sale182.4837868,978Aug 11 04:11 PM
DANIEL WOOLSONOfficerMay 22 '26Proposed Sale132.212,123280,685May 22 04:35 PM
Woolson DanielPresidentMay 22 '26Sale132.212,123280,68522,479May 22 03:47 PM
Sanzone Virginia RuthVP, General CounselMay 14 '26Sale124.082,447303,62419,460May 15 12:19 PM
VIRGINIA SANZONEOfficerMay 14 '26Proposed Sale124.082,447303,624May 14 06:48 PM
KENNEDY KOLLEEN TDirectorMay 13 '26Option Exercise0.001,25404,539May 13 09:29 PM
Hernandez LaurieDirectorMay 13 '26Option Exercise0.001,25404,862May 13 09:20 PM
FINNEY ELISHA WDirectorMay 13 '26Option Exercise0.001,25405,249May 13 09:11 PM
Abbey DonaldDirectorMay 13 '26Option Exercise0.001,25406,004May 13 08:52 PM
Hoffmeister David FDirectorMay 13 '26Option Exercise0.001,25406,004May 13 08:38 PM
Greenberg David C.DirectorMay 12 '26Option Exercise101.062,424244,96910,384May 13 08:31 PM
Greenberg David C.DirectorMay 13 '26Option Exercise0.001,25409,214May 13 08:31 PM
Greenberg David C.DirectorMay 12 '26Sale122.912,424297,9347,960May 13 08:31 PM
DAVID C GREENBERGDirectorMay 12 '26Proposed Sale122.912,424297,934May 12 05:39 PM
Voigtlander Christian B.Chief Operating OfficerMar 15 '26Option Exercise0.0014,648051,154Mar 16 04:34 PM
Woolson DanielVP, GM-Infusion CapitalMar 15 '26Option Exercise0.002,924025,897Mar 16 04:33 PM
Sousa BenChief Information OfficerMar 15 '26Option Exercise0.001,30006,044Mar 16 04:32 PM
Sanzone Virginia RuthVP, General CounselMar 15 '26Option Exercise0.007,324024,330Mar 16 04:31 PM
Jain VivekChairman and CEOMar 15 '26Option Exercise0.0021,9720134,106Mar 16 04:30 PM
Bonnell Brian MichaelChief Financial OfficerMar 15 '26Option Exercise0.0014,648076,097Mar 16 04:28 PM
Bonnell Brian MichaelChief Financial OfficerMar 08 '26Option Exercise0.0071,7570104,364Mar 09 04:32 PM
Bonnell Brian MichaelChief Financial OfficerMar 07 '26Option Exercise0.003,522033,870Mar 09 04:32 PM
Jain VivekChairman and CEOMar 08 '26Option Exercise0.00107,6350176,506Mar 09 04:21 PM
Jain VivekChairman and CEOMar 07 '26Option Exercise0.005,282071,790Mar 09 04:21 PM
Sousa BenChief Information OfficerMar 08 '26Option Exercise0.008,13408,283Mar 09 04:19 PM
Sousa BenChief Information OfficerMar 07 '26Option Exercise0.001,40901,888Mar 09 04:19 PM
Sanzone Virginia RuthVP, General CounselMar 08 '26Option Exercise0.0027,106030,424Mar 09 04:18 PM
Sanzone Virginia RuthVP, General CounselMar 07 '26Option Exercise0.002,34807,804Mar 09 04:18 PM
Woolson DanielVP, GM-Infusion CapitalMar 08 '26Option Exercise0.0018,300028,327Mar 09 04:15 PM
Woolson DanielVP, GM-Infusion CapitalMar 07 '26Option Exercise0.001,585012,882Mar 09 04:15 PM
Voigtlander Christian B.Chief Operating OfficerMar 08 '26Option Exercise0.0071,757079,421Mar 09 04:14 PM
Voigtlander Christian B.Chief Operating OfficerMar 07 '26Option Exercise0.003,52209,610Mar 09 04:14 PM
DANIEL WOOLSONOfficerNov 25 '25Proposed Sale152.352,897441,364Nov 25 04:09 PM
Woolson DanielVP, GM-Infusion CapitalNov 25 '25Sale152.352,897441,36411,297Nov 25 03:18 PM
FINNEY ELISHA WDirectorNov 11 '25Option Exercise103.761,285133,3325,280Nov 12 10:59 AM
FINNEY ELISHA WDirectorNov 11 '25Sale140.421,285180,4403,995Nov 12 10:59 AM
Sanzone Virginia RuthVP, General CounselNov 11 '25Sale142.34930132,3815,456Nov 12 10:55 AM
VIRGINIA SANZONEOfficerNov 11 '25Proposed Sale142.34930132,381Nov 12 10:27 AM
ELISHA W FINNEYDirectorNov 11 '25Proposed Sale140.421,285180,440Nov 12 09:05 AM
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
CEO & Chairman of the BoardMr. Vivek Jain
PresidentMr. Daniel Woolson
CFO & TreasurerMr. Brian Michael Bonnell
Chief Operating OfficerMr. Christian B. Voigtlander
Corporate VPMs. Virginia Ruth Sanzone